Tags

Type your tag names separated by a space and hit enter

The KID Study. I: Structural baseline characteristics of the Federal Insurance for Salaried Employees' Institution (BfA) diabetic patients in inpatient rehabilitation. Kissingen Diabetes Intervention Study.
Exp Clin Endocrinol Diabetes. 1996; 104(5):370-7.EC

Abstract

% of type I diabetics are not administering insulin according to the intensified conventional therapy schedules, only 16.8% of all type II diabetics are treated with diet only. Type II diabetics are much too often treated with pre-mixed insulins of too high dosage (26.2%) or with oral hypoglycemics (46.2%) of which 90% were sulphonylureas and nearly exclusively glibenclamide. Oral hypoglycemics with extrapancreatic activity or combined therapies were not common among the patients.

Authors+Show Affiliations

Saale-Klinik der BfA, Bad Kissingen, Germany.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

8957272

Citation

Haupt, E, et al. "The KID Study. I: Structural Baseline Characteristics of the Federal Insurance for Salaried Employees' Institution (BfA) Diabetic Patients in Inpatient Rehabilitation. Kissingen Diabetes Intervention Study." Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association, vol. 104, no. 5, 1996, pp. 370-7.
Haupt E, Herrmann R, Benecke-Timp A, et al. The KID Study. I: Structural baseline characteristics of the Federal Insurance for Salaried Employees' Institution (BfA) diabetic patients in inpatient rehabilitation. Kissingen Diabetes Intervention Study. Exp Clin Endocrinol Diabetes. 1996;104(5):370-7.
Haupt, E., Herrmann, R., Benecke-Timp, A., Vogel, H., Hilgenfeldt, J., Haupt, A., & Walter, C. (1996). The KID Study. I: Structural baseline characteristics of the Federal Insurance for Salaried Employees' Institution (BfA) diabetic patients in inpatient rehabilitation. Kissingen Diabetes Intervention Study. Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association, 104(5), 370-7.
Haupt E, et al. The KID Study. I: Structural Baseline Characteristics of the Federal Insurance for Salaried Employees' Institution (BfA) Diabetic Patients in Inpatient Rehabilitation. Kissingen Diabetes Intervention Study. Exp Clin Endocrinol Diabetes. 1996;104(5):370-7. PubMed PMID: 8957272.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The KID Study. I: Structural baseline characteristics of the Federal Insurance for Salaried Employees' Institution (BfA) diabetic patients in inpatient rehabilitation. Kissingen Diabetes Intervention Study. AU - Haupt,E, AU - Herrmann,R, AU - Benecke-Timp,A, AU - Vogel,H, AU - Hilgenfeldt,J, AU - Haupt,A, AU - Walter,C, PY - 1996/1/1/pubmed PY - 1996/1/1/medline PY - 1996/1/1/entrez SP - 370 EP - 7 JF - Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association JO - Exp Clin Endocrinol Diabetes VL - 104 IS - 5 N2 - % of type I diabetics are not administering insulin according to the intensified conventional therapy schedules, only 16.8% of all type II diabetics are treated with diet only. Type II diabetics are much too often treated with pre-mixed insulins of too high dosage (26.2%) or with oral hypoglycemics (46.2%) of which 90% were sulphonylureas and nearly exclusively glibenclamide. Oral hypoglycemics with extrapancreatic activity or combined therapies were not common among the patients. SN - 0947-7349 UR - https://www.unboundmedicine.com/medline/citation/8957272/The_KID_Study__I:_Structural_baseline_characteristics_of_the_Federal_Insurance_for_Salaried_Employees'_Institution__BfA__diabetic_patients_in_inpatient_rehabilitation__Kissingen_Diabetes_Intervention_Study_ L2 - http://www.thieme-connect.com/DOI/DOI?10.1055/s-0029-1211470 DB - PRIME DP - Unbound Medicine ER -